TABLE 4.
Comparisons of the number of re-exacerbations and the cumulative months of the antibiotic usage within 12 months.
| Drug group (n = 181) | Control group (n = 186) | P-value | |
|---|---|---|---|
| No. of re-exacerbation | 0.66 ± 0.91 | 0.92 ± 1.00 | 0.005 |
| Months of oral antibiotics | 1.29 ± 2.09 | 1.90 ± 2.33 | 0.001 |
| Months of intravenous antibiotics | 0.43 ± 0.79 | 0.65 ± 0.91 | 0.012 |
Data are presented as mean ± SD except as otherwise noted. No., number.